Skip to main content

Featured

Wall Street Eyes Weekly Gain as Peace Hopes Lift Futures

  Wall Street Poised for Weekly Gain as Futures Climb on Middle East Peace Hopes Wall Street looked set to close the week on a positive note as U.S. equity futures climbed Friday, supported by renewed optimism that diplomatic progress in the Middle East could ease geopolitical tensions. Investors have been highly sensitive to any signs of de‑escalation, and this week’s developments helped unwind some of the risk premiums that had weighed on global markets. Oil prices, which surged earlier in the month on fears of supply disruptions, pulled back again as ceasefire discussions gained traction. Lower energy costs have helped cool inflation expectations, giving markets a bit more breathing room after a volatile stretch. Major U.S. indexes are now on track for a weekly gain, with tech and consumer stocks leading the rebound. Still, analysts caution that sentiment remains fragile: any setback in negotiations could quickly revive market turbulence. For Canadian investors, easing oil v...
Post a Comment
Read more

article

Labels

Health Canada authorizes updated Pfizer-BioNTech COVID vaccine


Health Canada has authorized Pfizer-BioNTech’s updated COVID-19 vaccine for people six months and older.

The mRNA vaccine targets the Omicron XBB.1.5 subvariant that is circulating in Canada.

This is the second vaccine targeting XBB.1.5 that will be available in this country.

Earlier this month, Health Canada authorized Moderna's updated mRNA vaccine.

Both Pfizer and Moderna's shots are one-dose vaccines for people five years of age and older.

Three shots of the Pfizer vaccine is recommended for children between six months and four years of age who have not received their primary series of a COVID-19 vaccine.

Health Canada says it is currently reviewing an updated non-mRNA vaccine from Novavax.

Novavax’s vaccine has been submitted for consideration for people age 12 years and older.

Labels:

Comments

Post a Comment